REVIEW
Accepted on 24 Mar 2025
Eph/Ephrin-Mediated Immune Modulation: A Potential Therapeutic Target for Skin Cancer
doi 10.3389/fimmu.2025.1539567
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immunology and Immunotherapy of Skin Cancer
Immunology and Immunotherapy of Skin Cancer
7,162
Total downloads
25k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 24 Feb 2025
Treatment at the end of life in patients with advanced melanoma. A multicenter DeCOG study of 1067 patients from the prospective skin cancer registry ADOReg
doi 10.3389/fimmu.2025.1509886
- 693 views
ORIGINAL RESEARCH
Published on 14 Feb 2025
Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation status
doi 10.3389/fimmu.2025.1536642
- 685 views
CLINICAL TRIAL
Published on 04 Feb 2025
Phase I study of pembrolizumab in combination with ibrutinib for the treatment of unresectable or metastatic melanoma
doi 10.3389/fimmu.2025.1491448
- 873 views
SYSTEMATIC REVIEW
Published on 31 Jan 2025
Discontinuation of immune checkpoint inhibitors for reasons other than disease progression and the impact on relapse and survival of advanced melanoma patients. A systematic review and meta-analysis
doi 10.3389/fimmu.2025.1524945
- 1,259 views
REVIEW
Published on 24 Jan 2025
From actinic keratosis to cutaneous squamous cell carcinoma: the key pathogenesis and treatments
doi 10.3389/fimmu.2025.1518633
- 1,122 views
ORIGINAL RESEARCH
Published on 06 Jan 2025
SILAC-based quantification reveals modulation of the immunopeptidome in BRAF and MEK inhibitor sensitive and resistant melanoma cells
doi 10.3389/fimmu.2024.1490821
- 1,062 views
BRIEF RESEARCH REPORT
Published on 05 Dec 2024
Re-exposition to ipilimumab plus nivolumab in metastatic Merkel cell carcinoma
doi 10.3389/fimmu.2024.1495004
- 612 views
REVIEW
Published on 04 Dec 2024
The role of circulating tumor DNA in melanomas of the uveal tract
doi 10.3389/fimmu.2024.1509968
- 998 views
ORIGINAL RESEARCH
Published on 04 Sep 2024
A phase III study to access the safety and efficacy of prolgolimab 250 mg fixed dose administered every 3 weeks versus prolgolimab 1 mg/kg every 2 weeks in patients with metastatic melanoma (FLAT)
doi 10.3389/fonc.2024.1385685
- 1,413 views
REVIEW
Published on 16 Jul 2024
Recent advances in immunotherapy and its combination therapies for advanced melanoma: a review
doi 10.3389/fonc.2024.1400193
- 2,255 views
- 3 citations
ORIGINAL RESEARCH
Published on 12 Jul 2024
Real-world evidence study on the early use of cemiplimab in the UK: REACT-CEMI (Real World evidence of advanced CSCC treatment with cemiplimab)
doi 10.3389/fimmu.2024.1408667
- 2,439 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Vaccines and Molecular Therapeutics
Antigen Presenting Cell Biology
T Cell Biology
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: